ACCEPT DECLINE
Change Visitor Type Sign up to our newsletter

NEWS & VIEWS

Oxford Capital and our portfolio companies

Linkdex Welcomes Cormac Loughran As New CMO

By Oxford Capital February 5, 2015
Read More

BioMonde launches BioBag in US

By Oxford Capital January 30, 2015
Read More

Oxford Capital’s Renewable Energy Fund Featured In Environmental Finance

By Oxford Capital January 26, 2015
Our first renewable energy fund targeted at institutional investors has been profiled in Environmental Finance, a leading industry publication. You can access the full article here.
Read More

Green Biologics Closes Acquisition of Ethanol Plant in Minnesota

By Oxford Capital January 5, 2015
Read More

European VC is alive and well

By Oxford Capital December 17, 2014
The general perception of the European VC landscape is often held to be that of a distant poor relation to the freneticism, ambition and volume of the US West Coast. Fig 1. The Finnish PM takes the stage at Slush 2014 for the first day opening address Indeed, top level data from EVCN and Pitchbook…
Read More

$1 Billion Oncology Alliance between Menarini Group & Oxford BioTherapeutics

By Oxford Capital November 26, 2014
Read More

Veryan's BioMimics 3D Nitinol stent shows improved patency at 2-year follow-up in Mimics randomized controlled study

By Oxford Capital November 6, 2014
Read More

Outplay announces Monster Legacy has been nominated for Scottish BAFTA

By Oxford Capital October 23, 2014
Read More

Oxford Capital To Attend Major Infrastructure Investment Conference

By Oxford Capital October 3, 2014
Our investor relations team, who look after our growing base of institutional clients, are delighted to be involved with the AltAssets LP-GP Infrastructure Conference. At the event, which takes place in London on 7th October, we will be hosting a panel discussion entitled, “Filling the Vacuum: The emergence of new Infrastructure”. We will explore how…
Read More

Oxford BioTherapeutics Progress Antibody-Drug Conjugate as Second Clinical Development Candidate in $1 Billion Oncology Investment Alliance

By Oxford Capital October 2, 2014
Read More

Awards

  • BEST EIS
    FUND MANAGER
    2013,2012,2010 AND 2006

  • VENTURE CAPITAL
    HOUSE OF THE YEAR
    WINNER 2013 AND 2005

  • INVESTOR OF
    THE YEAR
    WINNER IN 2012 AND 2013

  • MOST IMPACTFUL
    INVESTMENT
    WINNER 2017

  • BEST ANGEL
    SYNDICATE
    WINNER 2018

  • BVCA Excellence in ESG
    GP CATEGORY
    COMMENDED 2020

  • VC INVESTOR OF THE YEAR
    GIANT HEALTH AWARDS
    WINNER 2020

  • EXIT OF THE YEAR
    ONE TO WATCH
    2020